NCT01353079View on ClinicalTrials.gov

Efficacy and Safety Study Of Short Ragweed Pollen Sublingual-Oral Immunotherapy

PHASE3CompletedINTERVENTIONAL

Enrollment

429

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

April 30, 2012

Conditions

Allergy

Interventions

BIOLOGICAL

Short Ragweed Pollen Allergenic Extract

Daily sublingual administration of Short Ragweed Pollen Allergenic Extract up to 42 U Amb a 1 for a minimum of 8 weeks prior to the ragweed pollen season.

BIOLOGICAL

Placebo

Placebo: Glycero-COCAs sublingual

Trial Locations (1)

20186

Site 7, Warrenton